Understanding the Human Health Effects of Chemical Mixtures

Environmental Health Perspectives Supplements v.110, n.1, Feb02

David O. Carpenter, Kathleen Arcaro, and David C. Spink

School of Public Health, Department of Environmental Health and Toxicology, University at Albany, State University of New York, Rensselaer, New York, USA

Abstract

Most research on the effects of chemicals on biologic systems is conducted on one chemical at a time. However, in the real world people are exposed to mixtures, not single chemicals. Although various substances may have totally independent actions, in many cases two substances may act at the same site in ways that can be either additive or nonadditive. Many even more complex interactions may occur if two chemicals act at different but related targets. In the extreme case there may be synergistic effects, in which case the effects of two substances together are greater than the sum of either effect alone. In reality, most persons are exposed to many chemicals, not just one or two, and therefore the effects of a chemical mixture are extremely complex and may differ for each mixture depending on the chemical composition. This complexity is a major reason why mixtures have not been well studied. In this review we attempt to illustrate some of the principles and approaches that can be used to study effects of mixtures. By the nature of the state of the science, this discussion is more a presentation of what we do not know than of what we do know about mixtures. We approach the study of mixtures at three levels, using specific examples. First, we discuss several human diseases in relation to a variety of environmental agents believed to influence the development and progression of the disease. We present results of selected cellular and animal studies in which simple mixtures have been investigated. Finally, we discuss some of the effects of mixtures at a molecular level. Key words: aromatic hydrocarbon receptor, cancer, cardiovascular disease, endocrine disruptors, metals, neurobehavioral abnormalities, neurodegenerative diseases, PAHs, PCBs, synergy. Environ Health Perspect 110(suppl 1):25-42 (2002).

source: http://ehpnet1.niehs.nih.gov/docs/2002/suppl-1/25-42carpenter/abstract.html 29aug02

References and Notes

1. Seed J, Brown RP, Olin SS, Foran JA. Chemical mixtures: current risk assessment methodologies and future directions. Reg Toxicol Pharmacol 22:76-94 (1995).

2. El-Masri HA, Readon KF, Yang RSH. Integrated approaches for the analysis of toxicologic interactions of chemical mixtures. Crit Rev Toxicol 27:175-197 (1997).

3. Carpenter DO, Arcaro KF, Bush B, Niemi WD, Pang SK. Vakharia DD. Human health and chemical mixtures: an overview. Environ Health Perspect 106(6):1263-1270 (1998).

4. Carpy SA, Kobel W, Doe J. Health risk of low-dose pesticides mixtures: a review of the 1985-1998 literature on combination toxicology and health risk assessment. J Toxicol Environ Health B Crit Rev 3:1-25 (2000).

5. Pimentel D, Tort M, D'Anna L, Krawic A, Gerger J, Rossman J, Mugo F, Doon N, Shriberg M, Howard E, et al. Ecology of increasing disease: population growth and environmental degradation. Bioscience 48:817-826 (1995).

6. Morrison HI, Villeneuve PJ, Lubin JH, Schaubel DE. Radon-progeny exposure and lung cancer risk in a cohort of Newfoundland fluorspar miners. Radiat Res 150:58-65 (1998).

7. Mendez D, Warner KE, Courant PN. Effects of radon mitigation vs smoking cessation in reducing radon-related risk of lung cancer. Am J Public Health 88:811-812 (1998).

8. Erren TC, Jacobson M, Piekarski C. Synergy between asbestos and smoking on lung cancer risks. Epidemiology 10:405-411 (1999).

9. Perera FP. Molecular epidemiology: Insights into cancer susceptibility, risk assessment, and prevention. J Natl Cancer Inst 88:496-509 (1996).

10. Safe S. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Crit Rev Toxicol 21:51-88 (1990).

11. Eadon G, Kaminsky L, Silkworth J, Aldous K, Hilker D, O'Keefe P, Smith R, Gierthy J, Hawley J, Kim N, et al. Calculation of 2,3,7,8-TCDD equivalent concentrations of complex environmental contaminant mixtures. Environ Health Perspect 70:221-227 (1986).

12. Wölfle D. Interactions between 2,3,7,8-TCDD and PCBs as tumor promoters: limitations of TEFs. Teratog Carcinog Mutagen 17:217-224 (1997-98).

13. Gierthy JF, Lincoln DW 2nd, Roth KE, Bowser SS, Bennett JA, Bradley L, Dickerman HW. Estrogen-stimulation of postconfluent cell accumulation and foci formation of human MCF-7 breast cancer cells. J Cell Biochem 45:177-187 (1991).

14. Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO. The E-screen assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect 103:113-122 (1995).

15. Murray CJL, Lopez AD. The Global Burden of Disease. Geneva:World Health Organization,1996.

16. Smith KR, Corvalan CF, Kjellstrom T. How much global ill health is attributable to environmental factors? Epidemiology 10:573-584 (1999).

17. Henriksen GL, Ketchum NS, Michalek JE, Swaby JA. Serum dioxin and diabetes mellitus in veterans of operation Ranch Hand. Epidemiology 8:252-258 (1997).

18. Vaarala O, Hyoty H, Akerblom HK. Environmental factors in the aetiology of childhood diabetes. Diabetes Nutr Metab 12:75-85 (1999).

19. Tseng C-H, Tai T-Y, Chong C-K, Tseng C-P, Lai M-S, Lin BJ, Chiou H-Y, Hsueh Y-M, Hsu K-K, Chen C-J. Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan. Environ Health Perspect 108:847-851 (2000).

20. Guo YL, Yu M-L, Hsu C-C, Rogan WJ. Chloracne, goiter, arthritis, and anemia after polychlorinated biphenyl poisoning: 14-year follow-up of the Taiwan Yucheng cohort. Environ Health Perspect 107:715-719 (1999).

21. Needleman H, Gunnoe C, Leviton A Peresie H, Maher C, Barret P. Deficits in psychological and classroom performance of children with elevated dentine lead levels. N Engl J Med 300:689-695 (1979).

22. Needleman H, Schell A, Bellinger D, Leviton A, Allred E. The long-term effects of exposure to low doses of lead in childhood: an 11-year follow-up report. N Engl J Med 322:83-88 (1990).

23. Rogan WJ, Dietrich KN, Ware JH, Dockery DW, Salganik M, Radcliffe J, Jones RL, Ragan NB, Chisolm JJ, Rhoads GG. Treatment of Lead-Exposed Children Trial Group. The effect of chelation therapy with succimr on neuropsychological development in children exposed to lead. N Engl J Med 344:1470-1471 (2001).

24. Chen Y-C, Guo Y-L, Hsu C-C, Rogan WJ. Cognitive development of Yu-Cheng ("oil disease") children prenatally exposed to heat-degraded PCBs. JAMA 268:3213-3218 (1992).

25. Yu M-LM, Hsu C-C, Guo YL, Lai T-J, Chen S-J, Luo J-M. Disordered behavior in the early-born Taiwan Yucheng children. Chemosphere 29:2413-2422 (1994).

26. Jacobsen JL, Jacobson SW. Intellectual impairment in children exposed to polychlorinated biphenyls in utero. N Engl J Med 335:783-789 (1996).

27. Stewart P, Reihman J, Lonky E, Darvill T, Pagano J. Prenatal PCB exposure and neonatal behavioral assessment scale (NBAS) performance. Neurotoxicol Teratol 22:21-29 (2000).

28. Rogan WJ, Gladen BC. Neurotoxicology of PCBs and related compounds. Neurotoxicology 13:27-35 (1992).

29. Clarkson TW. Methylmercury toxicity to the mature and developing nervous system: possible mechanisms. In: Biological Aspects of Metals and Metal-Related Diseases (Sarkar B, ed). New York:Raven Press, 1983;183-197.

30. Davidson PW, Myers GJ, Shamlaye C, Cox C, Gao P, Axtell C, Morris D, Sloane-Reeves J, Cernichiari E, et al. Association between prenatal exposure to methylmercury and developmental outcomes in Seychellois children: effect modification by social and environmental factors. Neurotoxicology 20:833-842 (1999).

31. Grandjean P, Weihe P, White RF, Dbes F. Cognitive performance of children prenatally exposed to "safe" levels of methylmercury. Environ Res A 77:165-172 (1998).

32. Mergler D, Belanger S, Larribe F, Panisset M, Bowler R, Baldwin M, Lebel J, Hudnell K. Preliminary evidence of neurotoxicity associated with eating fish from the upper St. Lawrence River lakes. Neurotoxicology 19:691-702 (1998).

33. Schantz SL, Gasior DM, Polverejan E, McCaffrey RJ, Sweeney AM, Humphrey HEB, Gardiner JC. Impairments of memory and learning in older adults exposed to polychlorinated biphenyls via consumption of Great Lakes fish. Environ Health Perspect 109:605-611 (2001).

34. Bemis JC, Seegal RF. Polychlorinated biphenyls and methylmercury act synergistically to reduce rat brain dopamine content in vitro. Environ Health Perspect 107:879-885 (1999).

35. Guillette EA, Meza MM, Aquilar MG, Soto A, Garcia IE. An anthropological approach to the evaluation of preschool children exposed to pesticides in Mexico. Environ Health Perspect 106:347-353 (1998).

36. Rice DC. Neurotoxicity of lead: commonalities between experimental and epidemiological data. Environ Health Perspect 104(suppl 2):337-351 (1996).

37. Rice DC. Behavioral impairment produced by low-level postnatal PCB exposure in monkeys. Environ Res A 80:S113-S121 (1999).

38. Schantz SL, Bowman RE. Learning in monkeys exposed perinatally to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Neurotoxicol Teratol 11:13-19 (1989).

39. Prendergast MA, Terry AV, Buccafusco JJ. Effects of chronic, low-level organophosphate exposure on delayed recall, discrimination, and spatial learning in monkeys and rats. Neurotoxicol Teratol 20:115-122 (1998).

40. Porterfield SP, Hendrich CE. The role of thyroid hormones in prenatal and neonatal neurological development--current perspectives. Endocr Rev 14:344-356 (1998).

41. Hussain RJ, Parsons PJ, Carpenter DO. Effects of lead on long-term potentiation in hippocampal CA3 vary with age. Dev Brain Res 121:243-252 (2001).

42. Hussain RJ, Gyori J, DeCaprio AP, Carpenter DO. In vivo and in vitro exposure to PCB 153 reduces long-term potentiation. Environ Health Perspect 108:827-831 (2000).

43. Nguyen PV, Abel T, Kandel ER, Bourtchouladze R. Strain-dependent differences in LTP and hippocampus-dependent memory in inbred mice. Learn Mem 7:170-179 (2000).

44. Niemi WD, Slivinski K, Audi J, Rej R, Carpenter DO. Propylthiouracil treatment reduces long-term potentiation in area CA1 of neonatal rat hippocampus. Neurosci Lett 210:127-129 (1996).

45. Newbold R. Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens. Environ Health Perspect 103:83-87 (1995).

46. Kovacevic R, Vojinovic-Miloradov M, Teodorovic I, Andric S. Effect of PCBs on androgen production by suspension of adult rat Leydig cells in vitro. J Steroid Biochem Mol Biol 52:595-597 (1995).

47. Gray LE. Xenoendocrine disrupters: laboratory studies on male reproductive effects. Toxicol Lett 102-103:331-335 (1998).

48. Kelce WR, Stone CR, Laws SC, Gray LE, Kemppalnen JA, Wilson EM. Persistent DDT metabolite p,p´-DDE is a potent androgen receptor antagonist. Nature 375:581-585 (1995).

49. Guo YL, Hse CC, Lambert GH. Effects of environmental chemicals (EC) on sexual maturation. Pediatr Res 39:74 (1996).

50. Blanck HM, Marcus M, Tolbert PE, Rubin C, Henderson AK, Hertzberg VS, Zhang RH, Cameron L. Age at menarche and tanner stage in girls exposed in utero and postnatally to polybrominated biphenyl. Epidemiology 11:641-647 (2000).

51. Pauwels A, Cenijn P, Covaci A. Analysis of PCB congeners by GC-ECD and dioxin-like toxic equivalents (by CALUX assay) in females with endometriosis and other fertility problems. Organohal Comp 44:407-410 (1999).

52. Carpenter DO, Shen Y, Nguyen T, Le L, Lininger LL. Incidence of endocrine disease among residents of New York Areas of Concern. Environ Health Perspect 109(6):845-851 (2001).

53. Rier SE, Turner WE, Martin DC, Morris R, Lucier GW, Clark GC. Serum levels of TCDD and dioxin-like chemicals in rhesus monkeys chronically exposed to dioxin: correlation of increased serum PCB levels with endometriosis. Toxicol Sci 59:147-159 (2001).

54. Mocarelli P, Gerthoux PM, Ferrari E, Patterson DG Jr, Kieszak SM, Bram P, Vincoli N, Signorini S, Tramacere P, Carreri V, et al. Paternal concentrations of dioxin and sex ratio of offspring. Lancet 355:1858-1863 (2000).

55. Pines A, Cucos S, Ever-Hardani P, Ron M. Some organochlorine insecticide and polychlorinated biphenyl blood residues in infertile males in the general Israeli population of the middle 1980s. Arch Environ Contam Tox 16:587-597 (1987).

56. Bush B, Bennett AH, Snow JT. Polychlorobiphenyl congeners, p,p'-DDE, and sperm function in humans. Arch Environ Contam Tox 15:333-341 (1986).

57. Emmett EA, Maroni M, Jefferys J, Schmith J, Levin BK, Alvares A. Studies of transformer repair workers exposed to PCBs. II: Results of clinical laboratory investigations. Am J Ind Med 14:47-62 (1988).

58. Apostoli P, Kiss P, Porru S, Bonde JP, Vanhoorne M, ASCLEPIOS study group. Male reproductive toxicity of lead in animals and humans. Occup Environ Med 55:364-374 (1998).

59. Sallmen M, Lindbohm ML, Nurminen M. Paternal exposure to lead and infertility. Epidemiology 11:148-152 (2000).

60. Lancranjan I, Popescu HI, Gavanescu O, Klepsch I, Serbanescu M. Reproductive ability of workmen occupationally exposed to lead. Arch Environ Health 30:396-401 (1975).

61. Telisman S, Cvitkovic P, Jurasovic J, Pizent A, Gavella M, Rocic B. Semen quality and reproductive endocrine function in relation to biomarkers of lead, cadmium, zinc, and copper in men. Environ Health Perspect 108:45-53 (2000).

62. Benoff S, Jacob A, Hurley IR. Male infertility and environmental exposure to lead and cadmium. Hum Reprod Update 6:107-121 (2000).

63. Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette LJ Jr, Jegou B, Jensen TK, Jouannet P, Keiding N, et al. Male reproductive health and environmental xenoestrogens. Environ Health Perspect 104(suppl 4):741-803 (1996).

64. Sharpe RM, Skakkebaek NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341:1392-1395 (1993).

65. McLachlan JA. Environmental estrogens and reproduction. Teratology 50:20 (1994).

66. Gorelick PB, Hier DB, Mangone C, Robbins S, Plioplys A, Kathpalia S. Status of aluminum as a risk factor for dialysis encephalopathy and Alzheimer's disease. Int J Artif Organs 14:70-73 (1991).

67. Martyn CN, Barker DJ, Osmond C, Harris EC, Edwardson JA, Lacey RF. Geographical relation between Alzheimer's disease and aluminum in drinking water. Lancet 1:59-62 (1989).

68. Yokel RA. Aluminum and Alzheimer's disease: should we worry? J Pharmacy Pract 1:118-127 (1988).

69. Shin R-W, Lee VM-Y, Trojanowski JQ. Aluminum modifies the properties of Alzheimer's disease PHFr proteins in vivo and in vitro. J Neurosci 14:7221-7233 (1994).

70. Yasui M, Yase Y, Ota K, Garruto GM. Aluminum deposition in the central nervous system of patients with amyotrophic lateral sclerosis from the Lii peninsula of Japan. Neurotoxicology 12:615-620 (1991).

71. Garruto RM, Fukatsu R, Yanagihara R, Gajdusek DC, Hook G, Fiori CE. Imaging of calcium and aluminum in neurofibrillary tangle-bearing neurons in Parkinsonism-dementia of Guam. Proc Natl Acad Sci U S A 81:1875-1879 (1984).

72. Campbell AMG, Williams ER, Barltrop D. Motor neuron disease and exposure to lead. J Neurol Neurosurg Psychiat 33:877-885 (1970).

73. Conradi S, Ronnevi L-O, Nise G. Abnormal tissue distribution of lead in amyotrophic lateral sclerosis--re-estimation of lead in the cerebrospinal fluid. J Neurol Sci 48:413-418 (1980).

74. House AO, Abbott RJ, Davidson DL, Ferguson IT, Lenman JA. Response to penicillamine of lead concentrations in CSF and blood in patients with motor neurone disease. Br Med J 2(6153):1684 (1978).

75. Kapaki E, Segditsa J, Zournas C, Xenos D, Papageorgiou C. Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases. Experientia 45:1108-1110 (1989).

76. Stober T, Stelte W, Kune K. Lead concentrations in blood plasma, erythrocytes and cerebrospinal fluid in amyotrophic lateral sclerosis. J Neurol Sci 61:21-26 (1983).

77. Strickland D, Smith SA, Dolliff G, Goldman L, Roelofs RI. Amyotrophic lateral sclerosis and occupational history. A pilot case-control study. Arch Neurol 53:730-733 (1996).

78. Prince M. Is chronic low-level lead exposure in early life an etiologic factor in Alzheimer's disease? Epidemiology 9:618-621 (1998).

79. Savolainen KM, Loikkanen J, Eerikainen S, Naarala J. Interactions of excitatory neurotransmitters and xenobiotics in excitotoxicity and oxidation stress: glutamate and lead. Toxicol Lett 102-103:363-367 (1998).

80. Jenner P, Schapira AHV, Marsden CD. New insights into the cause of Parkinson's disease. Neurology 42:2241-2250 (1992).

81. Gerlach M, Ben-Shachar D, Riederer P, Youdim MB. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 63:793-807 (1994).

82. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158:47-52 (1998).

83. Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y. Iron and aluminum increase in the substantia nigra of patient with Parkinson's disease: an X-ray microanalysis. J Neurochem 56:446-451 (1991).

84. Schulte PA, Burnett CA, Boeniger MF, Johnson J. Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991. Am J Public Health 86:1281-1288 (1996).

85. Koller W, Vetere-Overfield B, Gray C, Alexander C, Chin T, Dolezal J, Hassanein R, Tanner C. Environmental risk factors in Parkinson's disease. Neurology 40:1218-1221 (1990).

86. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ. The risk of Parkinson's disease with exposure to pesticides, farming, well water and rural living. Neurology 50:1346-1350 (1998).

87. Corrigan FM, Murray L, Wyatt CL, Shore RF. Diorthosubstituted polychlorinated biphenyls in caudate nucleus in Parkinson's disease. Exp Neurol 150:339-342 (1998).

88. Fleming L, Mann JB, Bean J, Briggle T, Sanchez-Ramos JR. Parkinson's disease and brain levels of organochlorine pesticides. Ann Neurol 36:100-103 (1994).

89. Corrigan FM, Wienburg CL, Shore RF, Daniel SE, Mann D. Organochlorine insecticides in substantia nigra in Parkinson's disease. J Toxicol Environ Health A 59:229-234 (2000).

90. Ho SC, Woo J, Lee CM. Epidemiologic study of Parkinson's disease in Hong Kong. Neurology 39:1314-1318 (1989).

91. Bhatt MH, Elias MA, Mankodi AK. Acute and reversible parkinsonism due to organophosphate pesticide intoxication. Five cases. Neurology 52:1467-1471 (1999).

92. Ferraz HB, Bertolucci PHF, Pereira JS, Lima JGC, Andrade LAF. Chronic exposure to the fungicide maneb may produce symptoms and signs of CNS manganese intoxication. Neurology 38:550-553 (1998).

93. Zeevalk GD, Bernard LP, Nicklas WJ. Role of oxidative stress and the glutathione system in loss of dopamine neurons due to impairment of energy metabolism. J Neurochem 70:14521-1430 (1998).

94. Haavik J, Almas B, Flatmark T. Generation of reactive oxygen species by tyrosine hydroxylase: a possible contribution to the degeneration of dopaminergic neurons? J Neurochem 68:328-332 (1997).

95. McGeer PL, Eccles JC, McGeer EG. Molecular Neurobiology of the Mammalian Brain. Second ed. New York:Plenum Press, 1987.

96. Graham DG. On the origin and significance of neuromelanin. Arch Path Lab Med 103:359-362 (1979).

97. Hastings TG, Lewis DA, Zigmond MJ. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci U S A 93:1956-1961 (1996).

98. Ben-Shachar D, Eshel G, Riederer P, Youdim MB. Role of iron and iron chelation in dopaminergic-induced neurodegeneration: implication for Parkinson's disease. Ann Neurol 32:S105-S110 (1992).

99. Zecca L, Pietra R, Goj C, Mecacci C, Radice D, Sabbioni E. Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain. J Neurochem 62:1097-1101 (1994).

100. Ben-Shachar D, Youdim MB. Iron, melanin and dopamine interaction: relevance to Parkinson disease. Prog Neuropsychopharmacol Biol Psychiatry 17:139-150 (1993).

101. Spina MB, Cohen G. Dopamine turnover and glutathione oxidation: implications for Parkinson's disease. Proc Natl Acad Sci U S A 86:1398-1400 (1989).

102. Dexter DT, Carter DJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 52:381-389 (1989).

103. Venitt S. Mechanisms of carcinogenesis and individual susceptibility to cancer. Clin Chem 40:1437-1425 (1994).

104. Holbrook JH. Nicotine addiction. In: Harrison' Principles of Internal Medicine (Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, eds). New York:McGraw-Hill 1998;2516-2519.

105. Perera FP. Environment and cancer: who are susceptible? Science 278:1068-1073 (1997).

106. National Toxicology Program. 9th Report on Carcinogens, 2000 Summary. Research Triangle Park, NC:National Toxicology Program, 2000.

107. Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci U S A 92:5258-5265 (1995).

108. Liehr JG. Dual role of oestrogens as hormones and procarcinogens--tumor initiation by metabolic activation of oestrogens. Eur J Cancer Prev 6:3-10 (1997).

109. Liehr JG. Genotoxicology of the steroidal oestrogens and oestradiol: possible mechanism of uterine and mammary cancer development. Hum Reprod Update 7:273-281 (2001).

110. Bradlow HL, Hershcopf RJ, Martucci CP, Fishman J. Estradiol 16-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. Proc Natl Acad Sci U S A 82:6295-6299 (1985).

111. Schneider J, Kinne D, Fracchia A, Pierce V, Anderson KE, Bradlow HL, Fishman J. Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc Natl Acad Sci U S A 79:3047-3051 (1982).

112. Tsutsui T, Suzuki N, Fukuda S, Sato G, Maisumi H, McLachlan JA, Barrett JC. 17ß-Estradiol-induced cell transformation and aneuploidy of Syrian hamster embryo cells in culture. Carcinogenesis 8:1715-1719 (1987).

113. Barrett JC, Wong A, McLachlan JA. Diethylstibestrol induces neolpastic transformation without measurable gene mutation at two loci. Science 212:1402-1404 (1981).

114. Li JJ, Li SA. Estrogen carcinogenesis in the hamster kidney: a hormone-driven multi-step process. In: Cellular Molecular Mechanisms of Hormonal Carcinogenesis: Environmental Influences (Huff J, Boyd J, Barrett JC, eds). Philadelphia: Wiley-Liss, 1996; 255-267.

115. Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S, Johansson SL, Patil KD, Gross ML, Gooden JK, et al. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci U S A 94:10937-10942 (1997).

116. Nutter LM, Ngo EO, Abul-Hajj YY. Characterization of DNA damage induced by 3,4-estrone-o-quinone in human cells. J Biol Chem 226:16380-16386 (1991).

117. Nutter LM, Wu YY, Ngo EO. An o-quinone form of estrogen produces free radicals in human breast cancer cells: correlation with DNA-damage. Chem Res Toxicol 7:273-281 (2001).

118. Bernstein L, Ross R. Endogenous hormones and breast cancer risk. Epidemiol Rev 15:48-65 (1993).

119. Toniolo P. Endogenous estrogens and breast cancer risk: the case for prospective cohort studies. Environ Health Perspect 105:587-592 (1997).

120. Goldin BR, Adlercreutz H, Gorbach SL, Woods MN, Dwyer JT, Conlon T, Bohn E, Gershoff SN. The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women. Am J Clin Nutr 44:945-953 (1986).

121. Key TJA, Chen J, Wang DY, Pike MC, Boreham J. Sex hormones in women in rural China and Britain. Br J Cancer 62:631-636 (1990).

122. Shimizu H, Ross RK, Bernstein L, Pike MC, Henderson BE. Serum estrogen levels in postmenopausal women: comparison of US whites and Japanese in Japan. Br J Cancer 62:451-454 (1990).

123. Ursin G, Wilson M, Henderson BE, Kolonel LN, Monroe K, Lee H-P, Seow A, Yu MC, Stancyzk, FZ, Gentzchein E. Do urinary estrogen metabolites reflect the differences in breast cancer risk between Singapore Chinese and United States African-American and white women? Cancer Res 61:3326-3329 (2001).

124. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101:372-377 (1993).

125. Dorgan JF, Brock JW, Rothman N, Needham LL, Miller R, Stephenson HE Jr, Schussler N, Taylor PR. Serum organochlorine pesticides and PCBs and breast cancer risk: results from a prospective analysis (USA). Cancer Causes Control 10:1-11 (1999).

126. Wolff MS, Toniolo PG. Environmental organochlorine exposure as a potential etiologic factor in breast cancer. Environ Health Perspect 103:141-145 (1995).

127. Safe SH. Interactions between hormones and chemicals in breast cancer. Annu Rev Pharmacol Toxicol 38:121-158 (1998).

128. Falck F Jr, Ricci A Jr, Wolff MS, Godbold J, Deckers P. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 47:143-146 (1992).

129. Wolff MS, Toniolo PG, Lee EW, Rivera M, Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 85:648-652 (1993).

130. Dewailly E, Dodin S, Verreault R, Ayotte P, Sauve L, Morin J, Brisson J. High organochlorine body burden in women with estrogen receptor-positive breast cancer. J Natl Cancer Inst 86:232-234 (1994).

131. Guttes S, Failing K, Neumann K, Kleinstein J, Georgii S, Brunn H. Chloroganic pesticides and polychlorinated biphenyls in breast tissue of women with benign and malignant breast disease. Arch Environ Contam Toxicol 35:140-147 (1998).

132. Unger M, Kiaer H, Blichert-Toft M, Olsen J, Clausen J. Organochlorine compounds in human breast fat from deceased with and without breast cancer and in a biopsy material from newly diagnosed patients undergoing breast surgery. Environ Res 34:24-28 (1984).

133. Kreiger N, Wolff MS, Hiatt RA, Rivera M, Vogelman J, Orentreich N. Breast cancer and serum organochlorines: a prospective study among white, black and Asian women. J Natl Cancer Inst 86:589-599 (1994).

134. Hunter DJ, Hankinson SE, Laden F, Colditz GA, Manson JE, Willett WC, Speizer FE, Wolff MS. Plasma organochlorine levels and the risk of breast cancer. N Engl J Med 337:1253-1258 (1997).

135. Lopez-Carrillo L, Blair A, Lopez-Cervantes M, Cebrian M, Rueda C, Reyes R, Mohar A, Bravo J. Dichlorodiphenyltrichloroethane serum levels and breast cancer risk: a case control study from Mexico. Cancer Res 57:3728-3732 (1997).

136. van't Veer P, Lobbezoo IE, Martin-Moreno JM, Guallar E, Gomez-Aracena J, Kardinaal AF, Kohlmeier L, Martin BC, Strain JJ, Thamm M, et al. DDT (dicophane) and postmenopausal breast cancer in Europe: case-control study. Br Med J 315:81-85 (1997).

137. Laden F, Collman G, Iwamoto K, Alberg A, Berkowitz GS, Freudenheim JL, Hankinson SE, Helzlsouer KJ, Holford TR, Huang HY, et al. 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five US studies. J Natl Cancer Inst 93:768-776 (2001).

138. Feigelson HS, Ross RK, Yu MC, Coetzee GA, Reichardt JV, Henderson BE. Sex steroid hormones and genetic susceptibility to breast and prostate cancer. Drug Metab Rev 30:421-434 (1998).

139. Feigelson HS, McKean-Cowdin R, Coetzee GA, Stranberg B, Kolstad HA, Henderson BE. Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1. Cancer Res 61:785-789 (2001).

140. Moysich KB, Shields PG, Freudenheim JL, Schisterman EF, Vena JE, Kostyniak P, Greizerstein H, Marshall JR, Graham S, Ambrosone CB. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 8:41-44 (1999).

141. Millikan R, DeVoto E, Duell EJ, Tse CK, Savitz DA, Beach J, Edmiston S, Jackson S, Newman B. Dichlorodiphenyldichlorethane, polychlorinated biphenyls, and breast cancer among African-American and white women in North Carolina. Cancer Epidemiol Biomarkers Prev 9:1233-1240 (2000).

142. Rundle A, Tang D, Hibshoosh H, Estabrook A, Schnabel F, Cao W, Grumet S, Perera FP. The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Carcinogenesis 7:1281-1289 (2000).

143. Rundle A, Tang D, Zhou J, Cho S, Perera F. The association between glutathione S-transferase M1 genotype and polycyclic aromatic hydrocarbon-DNA adducts in breast tissue. Cancer Epidemiol Biomarkers Prev 10:1079-1085 (2000).

144. Fielding JE. Smoking: Health effects and control. In: Public Health and Preventive Medicine, Twelfth ed (Last JM, ed). Norwalk, CT:Appleton-Century-Crofts 1986; 999-1038.

145. Chen C-J, Chiou H-Y, Chiang M-H, Lin L-J, Tai T-Y. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler Thromb Vasc Biol 16:504-510 (1996).

146. Salonen JT, Seppänen K, Nyyssönen K, Korpela H, Kauhanen J, Kantola M, Tuomilehto J, Esterbauer H, Tatzber F, Salonen R. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in Eastern Finnish men. Circulation 91:645-655 (1995).

147. Sørensen N, Murata K, Budtz-Jørgensen, Weihe P, Grandjean P. Prenatal methylmercury exposure as a cardiovascular risk factor at seven years of age. Epidemiology 10:370-375.

148. Kopp SJ, Barron JT, Tow JP. Cardiovascular actions of lead and relationship to hypertension: a review. Environ Health Perspect 78:91-99 (1988).

149. Hu H, Aro A, Payton M, Korrick S, Sparrow D, Weiss ST, Rotnitzky A. The relationship of bone and blood lead to hypertension. JAMA 275:1171-1176 (1996).

150. Flesch-Janys D, Berger J, Gurn P, Manz A, Nagel S, Waltsgott H, Dwyer JH. Exposure to polychlorinated dioxins and furans (PCDD/F) and mortality in a cohort of workers from a herbicide-producing plant in Hamburg, Federal Republic of Germany. Am J Epidemiol 142:1165-1175 (1995).

151. Hooiveld M, Heederik DJ, Kogevinas M, Boffetta P, Needham LL, Patterson DG, Bueno-de-Mesquita HB. Second follow-up of a Dutch cohort occupationally exposed to phenoxy herbicides, chlorophenols and contaminants. Am J Epidemiol 147:891-901 (1998).

152. Michalek JE, Ketchum NS, Akjhtar FX. Postservice mortality of US Air Force veterans occupationally exposed to herbicides in Vietnam: 15-year follow-up. Am J Epidemiol 148:786-792 (1998).

153. Vena J, Boffetta P, Becher H, Benn T, Bueno-de-Mesquita HB, Coggon D, Colin D, Flesch-Janys D, Green L, Kauppinen T, et al.. Exposure to dioxin and nonneoplastic mortality in the expanded IARC international cohort study of phenoxy herbicide and chlorophenol production workers and sprayers. Environ Health Perspect 106:645-653 (1998).

154. Pesatori AC, Zocchetti C, Guercilena S, Consonni D, Turrini D, Bertazzi PA. Dioxin exposure and non-malignant health effects: a mortality study. Occup Environ Med 55:126-131 (1998).

155. Patterson DG Jr, Todd GD, Turner WE, Maggio V, Alexander LR, Needham LL. Levels of non-ortho-substituted (coplanar), mono- and di-ortho-substituted polychlorinated biphenyls, dibenzo-p-dioxins and dibenzofurans in human serum and adipose tissues. Environ Health Perspect 102:195-204 (1994).

156. Baker EL Jr, Landrigan PJ, Glueck CJ, Zack MM Jr, Liddle JA, Burse VW, Housworth WJ, Needham LL. Metabolic consequences of exposure to polychlorinated biphenyls (PCB) in sewage sludge. Am J Epidemiol 112:553-563 (1980).

157. Smith AB, Schloemer J, Lowry LK, Smallwood AW, Ligo RN, Tanaka S, Stringer W, Jones M, Hervin R, Glueck CJ. Metabolic and health consequences of occupational exposure to polychlorinated biphenyls. Br J Ind Med 39:361-369 (1982).

158. Kreiss K. Studies on populations exposed to polychlorinated biphenyls. Environ Health Perspect 60:193-199 (1985).

159. Stehr-Green PA, Welty E, Steele G, Steinberg K. Evaluation of potential health effects associated with serum polychlorinated biphenyl levels. Environ Health Perspect 70:255-259 (1986).

160. Calvert CM, Wille KK, Sweeney MH, Fingerhut MA, Halperin WE. Evaluation of serum lipid concentrations among U.S. workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Environ Health 51:100-107 (1996).

161. Goldey ES, Kehn LS, Crofton KM. Developmental exposure to polychlorinated biphenyls (Aroclor 1254) reduces circulating thyroid hormone concentrations and causes hearing deficits in rats. Toxicol Appl Pharmacol 135:77-88 (1995).

162. Safe S. Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment. Crit Rev Toxicol 24:87-149 (1994).

163. Gasiewicz TA, Neal RA. 2,3,7,8-Tetrachlorodibenzo-p-dioxin tissue distribution, excretion, and effects on clinical chemical parameters in guinea pigs. Toxicol Appl Pharmacol 51:329-339 (1979).

164. Suskind R, Cholak J, Schater LJ. Unpublished data.

165. Boll M, Weber LWD, Messner B, Stampfl A. Polychlorinated biphenyls affect the activities of gluconeogenic and lipogenic enzymes in rat liver: is there an interference with regulatory hormone actions? Xenobiotica 28:479-492 (1998).

166. Stohs SJ. Oxidative stress induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Free Radic Biol Med 9:79-90 (1990).

167. Hassoun EA, Wilt SC, Devito MJ, Van Birgelen A, Alsharif NZ, Birnbaum LS, Stohs SJ. Induction of oxidative stress in brain tissues of mice after subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Sci 42:23-27 (1998).

168. Toborek M, Barger SW, Mattson M, Espandiari P, Robertson LW, Hennig B. Exposure to polychlorinated biphenyls causes endothelial cell dysfunction. J Biochem Toxicol 10:219-226 (1995).

169. Slim R, Toborek M, Robertson LW, Hennig B. Antioxidant protection against PCB-mediated endothelial cell activation. Toxicol Sci 52:232-239 (1999).

170. Hennig B, Slim R, Toborek M, Robertson LM. Alinoleic acid amplifies polychlorinated biphenyl-mediated dysfunction of endothelial cells. J Biochem Mol Toxicol 13:83-91 (1999).

171. Vayssier-Taussat M, Camilli T, Aron Y, Meplan C, Hainaut P, Polla BS, Weksler B. Effects of tobacco smoke and benzo[]pyrene on human endothelial cell and monocyte stress responses. Am J Heart Circ Physiol 280:H1293-H1300 (2001).

172. Spink DC, Lincoln DW, Dickerman HW, Gierthy JF. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17ß-estradiol metabolism in MCF-7 breast tumor cells. Proc Natl Acad Sci U S A 87:6917-6921 (1990).

173. Liehr JG. Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 21:40-54 (2000).

174. Parl FF. Estrogens, Estrogen Receptor, and Breast Cancer, Vol 36. In: Biomedical and Health Research. Nashville, TN:IOS Press, 2000.

175. Korach KS, Sarver P, Chae K, McLachlan JA, McKinney JD. Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: conformationally restricted structural probes. Mol Pharmacol 33:120-126 (1987).

176. Fielden MR, Chen I, Chittim B, Safe SH, Zacharewski TR. Examination of the estrogenicity of 2,4,6,2',6'-pentachlorobiphenyl (PCB 104), its hydroxylated metabolite 2,4,6,2',6'-pentachloro-4-biphenylol (HO-PCB 104), and a further chlorinated derivative, 2,4,6,2',4',6'-hexachlorobiphenyl (PCB 155). Environ Health Perspect 105:1238-1248 (1997).

177. Jansen HT, Cooke PS, Porcelli J, Liu T-C, Hansen LG. Estrogenic and antiestrogenic actions of PCBs in female rat: in vitro and in vivo studies. Reprod Toxicol 7:237-248 (1993).

178. Li MH, Hansen LG. Uterotropic and enzyme induction effects of 2,2',5-trichlorobiphenyl. Bull Environ Contam Toxicol 54:494-500 (1995).

179. Arcaro KF, Yi LD, Seegal RF, Vakharia DD, Yang Y, Spink DC, Brosch K, Gierthy JF. 2,2',6,6'-Tetrachlorobiphenyl is estrogenic in vitro and in vivo. J Cell Biochem 72: 94-102 (1999).

180. Sarkar DK, Liehr JG, Singletary KW. Role of estrogen in alcohol promotion of breast cancer and prolactinomas. Alcoholism: Clin Exp Res 25:230S-236S (2001).

181. Castro GD, Delagado de Layno AMA, Costantini MH, Castro JA. Cytosolic xanthine oxidoreductase mediated bioactivation of ethanol to acetaldehyde and free radicals in rat breast tissue. Its potential role in alcohol-promoted mammary cancer. Toxicology 160:11-18 (2001).

182. Schneider SL, Alks V, Morreal CE, Sinha DK, Dao TL. Estrogenic properties of 3,9-dihydroxybenz[a]anthracene, a potential metabolite of benz[a]anthracene. J Natl Cancer Inst 57:1351-1354 (1976).

183. Ebright RH, Wong JR, Chen LB. Binding of 2-hydroxybenzo(a)pyrene to estrogen receptors in rat cytosol. Cancer Res 46:2349-2351 (1986).

184. Sheen YY, Kim SS, Yun, HC. Effect of 3-methylcholanthrene on the rat uterus: uterine growth and mechanism of action of 3-methylcholanthrene. Arch Pharmacal Res 16:276-282 (1993).

185. Arcaro KF, O'Keefe PW, Yang Y, Clayton W, Gierthy JF. Antiestrogenicity of environmental polycyclic aromatic hydrocarbons in human breast cancer cells. Toxicology 133:115-127 (1999).

186. Fertuck KC, Kumar S, Sikka HC, Matthews JB, Zacharewski TR. Interaction of PAH-related compounds with the and ß isoforms of the estrogen receptor. Toxicol Lett 121:167-177 (2001).

187. Kledzik GS, Bradley CJ, Marshall S, Campbell GA, Meites J. Effects of high doses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats. Cancer Res 36:3265-3268 (1976).

188. Jordan VC. Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata. Eur J Cancer 12:419-424 (1976).

189. Jordan VC. Laboratory models of breast cancer to aid the elucidation of antiestrogen action. J Lab Clin Med 109:267-277 (1987).

190. Rubin BS, Murray MK, Damassa DA, King JC, Soto AM. Perinatal xposure to low doses of bisphenol A affects body weight patterns of estrous cyclicity, and plasma 1h levels. Environ Health Perspect 109:675-680 (2001).

191. Payne J, Scholze M, Kortenkamp A. Mixtures of four organochlorines enhance human breast cancer cell proliferation. Environ Health Perspect 109:391-397 (2001).

192. Rajapakse N, Ong D, Kortenkamp A. Defining the impact of weakly estrogenic chemicals on the action of steroidal estrogens. Toxicol Sci 60:296-304 (2001).

193. Hany J, Lilenthal H, Sarasin A, Roth-Harer A, Fastabend A, Dunemann L, Lichtensteiger W, Winneke G. Developmental exposure of rats to a reconstituted PCB mixture or Aroclor 1254: effects on organ weights, aromatase activity, sex hormone levels and sweet preference. Toxicol Appl Pharmacol 158:231-243 (1999).

194. Du K, Chu S, Xu X. Stimulation of MCF-7 cell proliferation by low concentrations of Chinese domestic polychlorinated biphenyls. J Toxicol Environ Health 61:201-207 (2000).

195. Meerts IATM, Letcher RJ, Hovinh S, Marsh G, Bergman A, Lemmen JG, Van den Berg M, Brouwer A. In vitro estrogenicity of polybrominated diphenyl ethers, hydroxylated PBDEs, and polybrominated bisphenol A compounds. Environ Health Perspect 109:399-407 (2001).

196. Mayes BA, Mcconnell EE, Neal BH, Brunner MJ, Hamilton SB, Sullivan TM, Peters AC, Ryan MJ, Toft JD, Singer AW, et al. Comparative carcinogenicity in Spraque-Dawley rats of the polychlorinated biphenyl mixtures Aroclors 1016, 1242, 1254, and 1260. Fundam Appl Toxicol 41:62-76 (1998).

197. Moore RW, Potter CL, Theobald HM, Robinson JA, Peterson RE. Androgenic deficiency in male rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 79:99-111 (1985).

198. Mably TA, Moore RW, Peterson RE. In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1: Effects of androgenic status. Toxicol Appl Pharmacol 114: 97-107 (1992).

199. Mably TA, Moore RW, Goy RW, Peterson RE. In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 2: Effects of sexual behavior and the regulation of luteinizing hormone secretion in adulthood. Toxicol Appl Pharmacol 114:108-117 (1992).

200. Mably TA, Bjerke DL, Moore RW, Gendron-Fitzpatrick A, Peterson RE. In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 3: Effects on spermatogenesis and reproductive capability. Toxicol Appl Pharmacol 114:118-126 (1992).

201. Bjerke DL, Peterson RE. Reproductive toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in male rats: different effects of in utero versus lactational exposure. Toxicol Appl Pharmacol 127:241-249 (1994).

202. Bjerke DL, Sommer RJ, Moore RW, Peterson RE. Effects of in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on responsiveness of the male rat reproductive system to testosterone stimulation in adulthood. Toxicol Appl Pharmacol 127:250-257 (1994).

203. Bjerke DL, Brown TJ, MacLusky NJ, Hochberg RB, Peterson RE. Partial demasculinization and feminization of sex behavior in male rats by in utero and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin is not associated with alterations in estrogen receptor binding or volumes of sexually differentiated brain nuclei. Toxicol Appl Pharmacol 127:258-267 (1994).

204. Gray LE Jr, Kelce WR, Monosson E, Ostby JS, Birnbaum LS. Exposure to TCDD during development permanently alters reproductive function in male Long Evans rats and hamsters: reduced ejaculated and epididmymal sperm numbers and sex accessory gland weights in offspring with normal androgenic status. Toxicol Appl Pharmacol 131:108-118 (1995).

205. Gray LE, Ostby JS, Kelce WR. A dose-reponse analysis of the reproductive effects of a single gestational dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin in male Long Evans hooded rat offspring. Toxicol Appl Pharmacol 146:11-20 (1997).

206. Moore RW, Peterson RE. Androgen catabolism and excretion in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats. Biochem Pharmacol 37:560-562 (1988).

207. McGivern RF, Sokol RZ, Berman NG. Prenatal lead exposure in the rat during the third week of gestation: long-term behavioral, physiological, and anatomical effects associated with reproduction. Toxicol Appl Pharmacol 110:206-215 (1991).

208. Ronis MJ, Gandy J, Badger T. Endocrine mechanisms underlying reproductive toxicity in the developing rat chronically exposed to dietary lead. J Toxicol Environ Health 54:77-99 (1998).

209 Sokol RZ, Madding CE, Swerdloff RS. Lead toxicity and the hypothalamic-pituitary-testicular axis. Biol Reprod 33:722-728 (1985).

210. Thoreux-Manlay A, Le Goascogne C, Segretain D, Jegou B, Pinon-Lataillade G. Lead affects steroidogenesis in rat Leydig cells in vivo and in vitro. Toxicology 103:53-62 (1995).

211. Hsu PC, Hsu CC, Liu MY, Chen LY, Guo YL. Lead-induced changes in spermatozoa function and metabolism. J Toxicol Environ Health 55:45-64 (1998).

212. Cooke PS, Zhao YD, Hansen LG. Neonatal polychlorinated biphenyl treatment increases adult testis size and sperm production in the rat. Toxicol Appl Pharmacol 136:112-117 (1996).

213. Machala M, Neca J, Drabek P, Ulrich R, Sabativa V, Nezveda K, Raszyk J, Gajduskova V. Effects of chronic exposure to PCBs on cytochrome P450 systems and steroidogenesis in liver and testis of bulls (Bos taurus). Comp Biochem Physiol A Mol Integr Physiol 120:65-70 (1998).

214. Haake-McMillan JM, Safe SH. Neonatal exposure to Aroclor 1254: effects on adult hapatic testosterone hydroxylase activities. Xenobiotica 21:481-489 (1991).

215. Minassian ES, Terner C. Biosynthesis of lipids by human fish spermatozoa. Am J Physiol 210:615-618 (1996).

216. Jones R, Mann T, Sherins R. Peroxidative breakdown of phospholipids in human spermatozoa, spermicidal properties of fatty acid peroxidases, and protective action of seminal plasma. Fertil Steril 31:531-537 (1979).

217. Kodama H, Yamaguchi R, Fukuda J, Kasai H, Tanaka T. Increased oxidative deoxyribonucleic acid damage in the spermatozoa of infertile male patients. Fertil Steril 68:519-524 (1997).

218. Ni ZY, Liu YQ, Shen HM, Chia SE, Ong CN. Does the increase of 8-hydroxydeoxyguanosine lead to poor sperm quality? Mutat Res 381:77-82 (1997).

219. Jozwik M, Jozwik M, Kuczynski W, Szamatowicz M. Nonenzymatic antioxidant activity of human seminal plasma. Fertil Steril 68:154-157 (1997).

220. Geva E, Bartoov B, Zabludovsky N, Lessing JB, Lerner-Geva L, Amit A. The effect of antioxidant on human spermatozoa and fertilization rate in an in vitro fertilization program. Fertil Steril 66:430-434 (1996).

221. Fraga CG, Motchink PA, Shigenaga MK, Helbock HJ, Jacob RA. Ascorbic acid protects against endogenous oxidative DNA damage in human sperm. Proc Natl Acad Sci U S A 88:11003-11006 (1991).

222. Fraga CG, Motchink PA, Wyrobek AJ, Rempel DM, Ames BN. Smoking and low antioxidant levels increase oxidative damage. Mutat Res 351:199-203 (1996).

223. Shen HM, Chia SE, Ni ZY, New AL, Lee BL, Ong CN. Detection of oxidative DNA damage in human sperm and the association with cigarette smoking. Reprod Toxicol 11:675-680 (1997).

224. Cahill A, Wang X, Hoek JB. Increased oxidative damage to mitochondrial DNA following chronic ethanol consumption. Biochem Biophys Res Commun 235:286-290 (1997).

225. Hsu PC, Liu MY, Hsu CC, Chen LY, Guo YL. Lead exposure causes generation of reactive oxygen species and functional impairment in rat sperm. Toxicology 122:133-143 (1997).

226. Marchlewicz M, Protasowicki M, Rozewicka L, Piasecka M, Laszczynska M. Effect of long-term exposure to lead on testis and epididymis in rats. Folia Histochem Cytobiol 31:55-62 (1993).

227. Amaro AR, Oakley GG, Bauer U, Spielmann HP, Robertson LW. Metabolic acitvtation of PCBs to quinones: reactivity toward nitrogen and sulfur nucleophiles and influence of superoxide dismutase. Chem Res Toxicol 9:623-629 (1996).

228. Oakley GG, Devanaboyina U, Robertson LW, Gupta MS. Oxidative DNA damage induced by activation of polychlorinated biphenyls (PCBs): implications for PCB-induced oxidative stress in breast cancer. Chem Res Toxicol 9:1285-1292 (1996).

229. Suchar LA, Chang RL, Thomas PE, Rosen RT, Lech J, Conney AH. Effects of phenobarbital, dexamethasone, and 3-methylcholanthrene administration on the metabolism of 17-beta-estradiol by liver microsomes from female rats Endocrinology 137:663-676 (1996).

230. Hansen LG. Stepping backward to improve assessment of PCB congener toxicities. Environ Health Perspect 106:171-189 (1998).

231. Guengerich FP, Dannan GA, Wright ST, Martin MV, Kaminsky LS. Purification and characterization of liver microsomal cytochromes P-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or beta-naphthoflavone. Biochemistry 21:6019-6030 (1982).

232. Li MH, Hansen LG. Enzyme induction and acute endocrine effects in prepubertal female rats receiving environmental PCB/PCDF/PCDD mixtures. Environ Health Perspect 104:712-722 (1996).

233. Brown JF. Determination of PCB metabolic, excretion, and accumulation rates for use as indicators of biological response and relative risk. Environ Sci Technol 28:2295-2305 (1994).

234. Hirose K, Morita M, Ema M, Mimura J, Hamada H, Fujii H, Saijo Y, Gotoh O, Sogawa K, Fujii-Kuriyama Y. cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix/PAS factor (Arnt2) with close sequence similarity to the aryl hydrocarbon receptor nuclear translocator (Arnt). Mol Cell Biol 16:1706-1703 (1996).

235. Keith B, Adelman DM, Simon MC. Targeted mutation of the murine arylhydrocarbon receptor nuclear translocator 2 (Arnt2) gene reveals partial redundancy with Arnt. Proc Natl Acad Sci U S A 98:6692-6697 (2001).

236. Honkakoski P, Negishi M. Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem J 347:321-337 (2000).

237. Wei P, Zhang J, Egan-Hafley M, Liang SG, Moore DD. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 407:920-923 (2000).

238. Xie W, Barwick JL, Simon CM, Pierce AM, Safe S, Blumberg B, Guzelian PS, Evans RM. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev 14:3014-3023 (2000).

239. Trottier E, Belzil A, Stoltz C, Anderson A. Localization of a phenobarbital-responsive element (PBRE) In the 5'-flanking region of the rat CYP2B2 gene. Gene 158:263-268 (1995).

240. Sueyoshi T, Kawamoto T, Zelko I, Honkakoski P, Negishi M. The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J Biol Chem 274:6043-6046 (1999).

241. Sueyoshi T, Negishi M. Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annu Rev Pharmacol Toxicol 41:123-143 (2001).

242. Yoshinari K, Sueyoshi T, Moore R, Negishi M. Nuclear receptor CAR as a regulatory factor for the sexually dimorphic induction of CYP2B1 gene by phenobarbital in rat livers. Mol Pharmacol 59:278-284 (2001).

243. Smirlis D, Muangmoonchai R, Edwards M, Phillips IR, Shepard, EA. Orphan receptor promiscuity in the induction of P450 by xenobiotics. J Biol Chem 276:12822-12826 (2001).

244. Schuetz EG, Brimer C, Schuetz JD. Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element. Mol Pharmacol 54:1113-1117 (1998).

245. Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, et al. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275:15122-15127 (2000).

246. Waxman DJ. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch Biochem Biophys 369:11-23 (1999).

247. Schilter B, Andersen MR, Acharya C, Omiecinski CJ. Activation of cytochrome P450 gene expression in the rat brain by phenobarbital-like inducers. J Pharmacol Exp Ther 294:916-922 (2000).

248. Lemieux PM, Lutes CC, Abbott JA, Aldous KM. Emissions of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans from the open burning of household waste in barrels. Environ Sci Technol 34:377-384 (2000).

249. Whitlock JP Jr, Okino ST, Dong L, Ko HP, Clarke-Katzenberg R, Ma Q, Li H. Cytochromes P450 5: induction of cytochrome P4501A1: a model for analyzing mammalian gene transcription. FASEB J 10:809-818 (1996).

250. Rowland JC, Gustafsson JA. Aryl hydrocarbon receptor-mediated signal transduction. Crit Rev Toxicol 27:109-134 (1997).

251. Jones LC, Whitlock JP Jr. Dioxin-inducible transactivation in an chromosomal setting. J Biol Chem 276:25037-25042 (2001).

252. Okino ST, Whitlock JP Jr. Dioxin induces localized, graded changes in chromatin structure--implications for CYP1A1 gene transcription. Mol Cell Biol 15:3714-3721 (1995).

253. Kumar MB, Tarpey RW, Perdew GH. Differential recruitment of coactivator RIP140 by Ah and estrogen receptors - absence of a role for LXXL motifs. J Biol Chem 274:22155-22164 (1999).

254. Ma Q, Whitlock JP. A novel cytoplasmic protein that interacts with the Ah receptor, contains tetratricopeptide repeat motifs, and augments the transcriptional response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Biol Chem 272:8878-8884 (1997).

255. Carver LA, LaPres JJ, Jain S, Dunham EE, Bradfield CA. Characterization of the Ah receptor-associated protein, ARA9. J Biol Chem 273:33580-33587 (1998).

256. Elferink CJ, Ge NL, Levine A. Maximal arylhydrocarbon receptor activity depends on an interaction with the retinoblastoma protein. Mol Pharmacol 59:664-673 (2001).

257. Klinge CM, Jernigan SC, Risinger KE, Lee JE, Tyulmenkov VV, Falkner KC, Prough RA. Short heterodimer partner (SHP) orphan nuclear receptor inhibits the transcriptional activity of aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT). Arch Biochem Biophys 390:64-70 (2001).

258. Tian Y, Ke S, Denison MS, Rabson AB, Gallo MA. Ah receptor and NF-B interactions, a potential mechanism for dioxin toxicity. J Biol Chem 274:510-515 (1999).

259. Davarinos NA, Pollenz RS. Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via cytoplasmic proteasome following nuclear export. J Biol Chem 274:28708-28715 (1999).

260. Ma Q, Baldwin KT. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced degradation of aryl hydrocarbon receptor (AhR) by the ubiquitin-proteasome pathway--role of the transcription activation and DNA binding of AhR. J Biol Chem 275:8432-8438 (2000).

261. Baba T, Mimura J, Gradin K, Kuroiwa A, Watanabe T, Matsuda Y, Inazawa J, Sogawa K, Fujii-Kuriyama Y. Structure and expression of the Ah receptor repressor gene. J Biol Chem 276:33101-33110 (2001).

262. Ma Q, Whitlock JP Jr. The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Mol Cell Biol 16:2144-2150 (1996).

263. Chang C-Y, Puga A. Constitutive activation of the aromatic hydrocarbon receptor. Mol Cell Biol 18:525-535 (1998).

264. Dey A, Nebert DW. Markedly increased constitutive CYP1A1 mRNA levels in the fertilized ovum of the mouse. Biochem Biophys Res Commun 251:657-661 (1998).

265. Adachi J, Mori Y, Matsui S, Takigami H, Fujino J, Kitagawa H, Miller CA 3rd, Kato T, Saeki K, Matsuda T. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J Biol Chem 276:31475-31478 (2001).

266. Spivack SD, Fasco MJ, Walker VE, Kaminsky LS. The molecular epidemiology of lung cancer. Crit Rev Toxicol 27:319-365 (1997).

267. Wood AW, Levin W, Lu AY, Yagi H, Hernandez O, Jerina DM, Conney AH. Metabolism of benzo(a)pyrene and benzo(a)pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes. J Biol Chem 251:4882-4890 (1976).

268. Kapitulnik J, Wislocki PG, Levin W, Yagi H, Jerina DM, Conney AH. Tumorigenicity studies with diol-epoxides of benzo()pyrene which indicate that (+/-)-trans-7ß, 8- dihydroxy-9 ,10 -epoxy-7,8,9,10-tetrahydrobenzo()pyrene is an ultimate carcinogen in newborn mice. Cancer Res 38:354-358 (1978).

269. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, Sutter TR. Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Res 56:2979-2984 (1996).

270. Spivack SD, Hurteau GJ, Reilly AA, Aldous KM, Ding XX, Kaminsky LS. CYP1B1 expression in human lung. Drug Metab Dispos 29:916-922 (2001).

271. Kim JH, Stansbury KH, Walker NJ, Trush MA, Strickland PT, Sutter TR. Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis 19:1847-1853 (1998).

272. Shimada T, Gillam EMJ, Oda Y, Tsumura F, Sutter TR, Guengerich FP, Inoue K. Metabolism of benzo[]pyrene to trans-7,8-dihydroxy-7,8-dihydrobenzo[]pyrene by recombinant human cytochrome P4501B1 and purified liver epoxide hydrolase. Chem Res Toxicol 12:623-629 (1999).

273. Jones SA, Moore LB, Shenk JL, Wisely GB, Hamilton GA, McKee DD, Tomkinson NCO. LeCluyse EL, Lambert MH, Willson TM, et al. The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol Endocrinol 14:27-39 (2000).

274. Denissenko MF, Pao A, Tang MS, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 274:430-432 (1996).

275. Willett KL, Randerath K, Zhou GD, Safe SH. Inhibition of CYP1A1-dependent activity by the polynuclear aromatic hydrocarbon (PAH) fluoranthene. Biochem Pharmacol 55:831-839 (1998).

276 Marston CP, Pereira C, Ferguson J, Fischer K, Hedstrom O, Dashwood WM, Baird WM. Effect of a complex environmental mixture from coal tar containing polycyclic aromatic hydrocarbons (PAH) on the tumor initiation, PAH-DNA binding and metabolic activation of carcinogenic PAH in mouse epidermis. Carcinogenesis 22:1077-1086 (2001).

277. Cherng S-H, Lin P, Yang JL, Hsu SL, Lee H. Benzo[g,h,i]perylene synergistically transactivates benzo[a]pyrene-induced CYP1A1 gene expression by aryl hydrocarbon receptor pathway. Toxicol Appl Pharmacol 170:63-68 (2001).

278. Gray DL, Warshawsky D, Xue WL, Nines R, Wang Y, Yao RS, Stoner GD. The effects of a binary mixture of benzo(a)pyrene and 7H-dibenzo(c,g)carbazole on lung tumors and K-ras oncogene mutations in strain A/J mice. Exp Lung Res 27:245-253 (2001).

279. Falahatpisheh MH, Donnelly KC, Ramos KS. Antagonistic interactions among nephrotoxic polycyclic aromatic hydrocarbons. J Toxicol Environ Health 62:543-560 (2001).

280. Burczynski ME, Penning TM. Genotoxic polycyclic aromatic hydrocarbon ortho-quinones generated by aldo-keto reductases induce CYP1A1 via nuclear translocation of the aryl hydrocarbon receptor. Cancer Res 60:908-915 (2000).

281. Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ. Role of quinones in toxicology. Chem Res Toxicol 13:135-160 (2000).

282. Long DJ, Waikel RL, Wang XJ, Perlaky L, Roop DR, Jaiswal AK. NAD(P)H: quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12-dimethylbenz[a]-anthracene-induced carcinogenesis in mouse skin. J Natl Cancer Inst 93:1166-1170 (2001).

283. Long DJ, Waikel RL, Wang XJ, Perlaky L, Roop DR, Jaiswal AK. NAD(P)H: quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis. Cancer Res 60:5913-5915 (2000).

284. Schmidt JV, Su G H-T, Reddy JK, Simon MC, Bradfield CA. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci U S A 93:6731-6736 (1996).

285. Maltepe E, Schmidt JV, Baunoch D, Bradfield CA, Simon MC. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386:403-407 (1997).

286. Tomita S, Sinal CJ, Yim SH, Gonzalez FJ. Conditional disruption of the aryl hydrocarbon receptor nuclear translocator (Arnt) gene leads to loss of target gene induction by the aryl hydrocarbon receptor and hypoxia-inducible factor 1. Mol Endocrinol 14:1674-1681 (2000).

287. Gradin K, Mcguire J, Wenger RH, Kvietikova I, Whitelaw ML, Toftgard R, Tora L, Gassmann M, Poellinger L. Functional interference between hypoxia and dioxin signal transduction pathways--competition for recruitment of the ARNT transcription factor. Mol Cell Biol 16:5221-5231 (1996).

288. Chan WK, Yao G, Gu YZ, Bradfield CA. Cross-talk between the aryl hydrocarbon receptor and hypoxia inducible factor signaling pathways--demonstration of competition and compensation. J Biol Chem 274:12115-12123 (1999).

289. Nie M, Blankenship AL, Giesy JP. Interactions between aryl hydrocarbon receptor (AhR) and hypoxia signaling pathways. Environ Toxicol Pharmacol 10:17-27 (2001).

290. Liu PCC, Matsumura F. Differential effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the adipose-type and brain-type glucose transporters in mice. Mol Pharmacol 47:65-73 (1995).

291. Ge NL, Elferink CJ. A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein - linking dioxin signaling to the cell cycle. J Biol Chem 273:22708-22713 (1998).

292. Puga A, Barnes SJ, Dalton TP, Chang CY, Knudsne ES, Maier MA. Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. J Biol Chem 275:2943-2950 (1999).

293. Kolluri SK, Weiss C, Koff A, Göttlicher M. p27Kip1 induction and inhibition of proliferation by intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev 13:1742-1753 (1999).

294. Matikainen T, Perez GI, Jurisicova A, Pru JK, Schlezinger JJ, Ryu HY, Laine J, Sakai T, Korsmeyer SJ, Casper RF, et al. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat Genet 28:355-360 (2001).

295. Maier A, Dalton TP, Puga A. Disruption of dioxin-inducible phase I and phase II gene expression patterns by cadmium, chromium, and arsenic. Mol Carcinog 28:225-235 (2000).

296. Liu SX, Athar M, Lippai I, Waldren C, Hei TK. Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. Proc Natl Acad Sci U S A 98:1643-1648 (2001).

297. Romero DL, Mounho BJ, Lauer FT, Born JL, Burchiel SW. Depletion of glutathione by benzo(a)pyrene metabolites, ionomycin, thapsigargin, and phorbol myristate in human peripheral blood mononuclear cells. Toxicol Appl Pharmacol 144:62-69 (1997).

298. Shertzer HG, Nebert DW, Puga A, Ary M, Sonntag D, Dixon K, Robinson LJ, Cianciolo E, Dalton TP. Dioxin causes a sustained oxidative stress response in the mouse. Biochem Biophys Res Commu 253:44-48 (1998).

299. Twaroski TP, O'Brien ML, Robertson LW. Effects of selected polychlorinated biphenyl (PCB) congeners on hepatic glutathione, glutathione-related enzymes, and selenium status: implications for oxidative stress. Biochem Pharmacol 62:273-281 (2001).

300. Dalton TP, Shertzer HG, Puga A. Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol Toxicol 39:67-101 (1999).

301. Ishii T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S, Yamamoto M. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 275:16023-16029 (2000).

302. Jeyapaul J, Jaiswal AK. Nrf2 and c-Jun regulation of antioxidant response element (ARE)-mediated expression and induction of gamma-glutamylcysteine synthetase heavy subunit gene. Biochem Pharmacol 59:1433-1439 (2000).

303 Yu R, Chen C, Mo YY, Hebbar V, Owuor ED, Tan TH, Kong AN. Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism. J Biol Chem 275:39907-39913 (2000).

304. Alam J, Stewart D, Touchard C, Boinapally S, Choi AMK, Cook JL. Nrf2, a cap'n'collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem 274:26071-26078 (1999).

305. Faux SP, Francis JE, Smith AG, Chipman JK. Induction of 8-hydroxydeoxyguanosine in Ah-responsive mouse liver by iron and Aroclor 1254. Carcinogenesis 13:247-250 (1992).

306. Park JYK, Shigenaga MK, Ames BN. Induction of cytochrome P4501A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin or indolo(3,2-b)carbazole is associated with oxidative DNA damage. Proc Natl Acad Sci U S A 93:2322-2327 (1996).

307. Jacobs JM, Nichols CE, Andrew AS, Marek DE, Wood SG, Sinclair PR, Wrighton SA, Kostrubsky VE, Sinclair JF. Effect of arsenite on induction of CYP1A, CYP2B, and CYP3A in primary cultures of rat hepatocytes. Toxicol Appl Pharmacol 157:51-59 (1999).

308. Vakharia DD, Liu N, Pause R, Fasco M, Bessette E, Zhang QY, Kaminsky LS. Effect of metals on polycyclic aromatic hydrocarbon induction of CYP1A1 and CYP1A2 in human hepatocyte cultures. Toxicol Appl Pharmacol 170:93-103 (2001).

309. Barker CW, Fagan JB, Pasco DS. Down-regulation of P4501A1 and P450 1A2 in isolated hepatocytes by oxidative stress. J Biol Chem 269:3985-3990 (1994).

310. Morel Y, Barouki R. Down-regulation of cytochrome P4501A1 gene promoter by oxidative stress--critical contribution of nuclear factor 1. J Biol Chem 273:26969-26976 (1998).

311. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071 (1997).

312. Li NX, Karin M. Is NF-kappa B the sensor of oxidative stress? FASEB J 13:1137-1143 (1999).

313. Chen F, Lu Y, Zhang Z, Vallyathan V, Ding M, Castranova V, Shi X. Opposite effect of NF-B and C-Jun N-terminal kinase on p53-independent GADD45 induction by arsenite. J Biol Chem 276:11414-11419 (2001).

314. Wijeweera JB, Gandolfi AJ, Parrish A, Lantz RC. Sodium arsenite enhances AP-1 and NF kappa B DNA binding and induces stress protein expression in precision-cut rat lung slices. Toxicol Sci 61:283-294 (2001).

315. Kapahi P, Takahashi T, Natoli G, Adams SR, Chen Y, Tsien RY, Karin M. Inhibition of NF-kappa B activation by arsenite through reaction with a critical cysteine in the activation loop of Ikappa B kinase. J Biol Chem 275:36062-3606 (2000).

316. Barker CW, Fagan JB, Pasco DS. Interleukin-1 beta suppresses the induction of P4501A1 and P4501A2 mRNAs in isolated hepatocytes. J Biol Chem 267(12):8050-8055 (1992).

317. Ke S, Rabson AB, Germino JF, Gallo MA, Tian Y. Mechanism of suppression of cytochrome P4501A1 expression by TNF-alpha and lipopolysaccharide. J Biol Chem 276:39638-39644 (2001).

318. Bae D-S, Chris Gennings C, Carter WH Jr, Yang RSH, Campain JA Toxicological interactions among arsenic, cadmium, chromium, and lead in human keratinocytes. Toxicol Sci 63:132-142 (2001).

319. Wormhoudt LW, Commandeur JNM, Vermeulen NPE. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity. Crit Rev Toxicol 29:59-124 (1999).

320. Hirvonen A. Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environ Health Perspect 107:37-47 (1999).

321. Nebert DW, Ingelman-Sundberg M, Daly AK. Genetic epidemiology of environmental toxicity and cancer susceptibility: human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues. Drug Metab Rev 31:467-487 (1999).

322. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, Michalek AM, Laughlin R, Nemoto T, Gillenwater KA, et al. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 276:1494-1501 (1996).

323. Bartosiewicz MJ, Jenkins D, Penn S, Emery J, Buckpitt A. Unique gene expression patterns in liver and kidney associated with exposure to chemical toxicants. J Pharmacol Exp Ther 297:895-905 (2001).

324. Bartosiewicz M, Penn S, Buckpitt A. Applications of gene arrays in environmental toxicology: fingerprints of gene regulation associated with cadmium chloride, benzo(a)pyrene, and trichloroethylene. Environ Health Perspect 109:71-74 (2001).

325. Pennie WD, Woodyatt NJ, Aldridge TC, Orphanides G. Application of genomics to the definition of the molecular basis for toxicity. Toxicol Lett 120:353-358 (2001).

326. Robertson JA. Consent and privacy in pharmacogenetic testing. Nat Genet 28:207-209 (2001).

Last Updated: January 26, 2002